Abstract |
Medullary thyroid carcinoma (MTC) is a neuroendocrine (NE) malignancy that frequently metastasizes and has limited treatments. We recently reported that ectopic expression of Notch-1 in human MTC cells suppresses growth. The objective of this study was to evaluate the ability of suberoyl bis-hydroxamic acid (SBHA) to modulate Notch-1 signaling in MTC cells. At baseline, no active Notch-1 protein was present in MTC cells. Treatment with SBHA resulted in a dose-dependent induction of the Notch-1 intracellular domain, the active form of the protein. Furthermore, with Notch-1 activation there was a concomitant decrease in achaete-scute complex-like 1 (ASCL-1), a downstream target of Notch-1 signaling, as well as the NE tumor marker chromogranin A (CgA). Transfection of Notch-1 small-interfering RNA into MTC cells blocked the effects of SBHA on Notch-1 activation, ASCL-1, and CgA. Importantly, SBHA treatment resulted in a dose-dependent decrease in cell viability. Treated cells had an increase in protein levels of cleaved caspase-3 and poly ADP-ribose polymerase, and changes in the expression of apoptotic mediators including Bcl-X(L) and Bad, indicating that the growth inhibition was a result of apoptosis. These results demonstrate that SBHA activates Notch-1 signaling, which is associated with the antiproliferative and apoptotic effects in MTC cells. Therefore, Notch-1 activation with SBHA is an attractive new strategy for the treatment of patients with MTC.
|
Authors | Li Ning, David Yu Greenblatt, Muthusamy Kunnimalaiyaan, Herbert Chen |
Journal | The oncologist
(Oncologist)
Vol. 13
Issue 2
Pg. 98-104
(Feb 2008)
ISSN: 1083-7159 [Print] England |
PMID | 18305053
(Publication Type: Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't)
|
Chemical References |
- Antineoplastic Agents
- Biomarkers, Tumor
- Chromogranin A
- Hydroxamic Acids
- NOTCH1 protein, human
- Receptor, Notch1
- suberoyl bis-hydroxamic acid
- Poly(ADP-ribose) Polymerases
- Caspase 3
|
Topics |
- Antineoplastic Agents
(pharmacology)
- Apoptosis
(drug effects)
- Biomarkers, Tumor
(metabolism)
- Blotting, Western
- Carcinoma, Medullary
(drug therapy, metabolism, physiopathology)
- Caspase 3
(metabolism)
- Cell Proliferation
(drug effects)
- Chromogranin A
(metabolism)
- Down-Regulation
- Gene Expression Regulation, Neoplastic
- Humans
- Hydroxamic Acids
(pharmacology)
- Poly(ADP-ribose) Polymerases
(drug effects)
- Receptor, Notch1
(drug effects, metabolism)
- Signal Transduction
(drug effects)
- Thyroid Neoplasms
(drug therapy, metabolism, physiopathology)
- Tumor Cells, Cultured
|